These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1216 related items for PubMed ID: 30208901

  • 1. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N, Bobrus-Chociej A, Harasim-Symbor E, Tarasów E, Wojtkowska M, Chabowski A, Lebensztejn DM.
    Lipids Health Dis; 2018 Sep 12; 17(1):216. PubMed ID: 30208901
    [Abstract] [Full Text] [Related]

  • 2. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Białokoz-Kalinowska I, Kłusek-Oksiuta M, Tarasów E, Wojtkowska M, Kaczmarski M.
    Adv Med Sci; 2014 Mar 12; 59(1):81-4. PubMed ID: 24797980
    [Abstract] [Full Text] [Related]

  • 3. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children.
    Flisiak-Jackiewicz M, Bobrus-Chociej A, Tarasów E, Wojtkowska M, Białokoz-Kalinowska I, Lebensztejn DM.
    Can J Gastroenterol Hepatol; 2018 Mar 12; 2018():3870454. PubMed ID: 29854715
    [Abstract] [Full Text] [Related]

  • 4. Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children.
    Kłusek-Oksiuta M, Bialokoz-Kalinowska I, Tarasów E, Wojtkowska M, Werpachowska I, Lebensztejn DM.
    Ital J Pediatr; 2014 Nov 17; 40():84. PubMed ID: 25399407
    [Abstract] [Full Text] [Related]

  • 5. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E, Aydın S, Gökçe S, Özgen İT, Donmez T, Cesur Y.
    Turk J Gastroenterol; 2014 Dec 17; 25 Suppl 1():92-8. PubMed ID: 25910377
    [Abstract] [Full Text] [Related]

  • 6. Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease.
    Kopiczko N, Bobrus-Chociej A, Harasim-Symbor E, Tarasów E, Wojtkowska M, Chabowski A, Lebensztejn DM.
    Nutrition; 2022 Feb 17; 94():111541. PubMed ID: 34974284
    [Abstract] [Full Text] [Related]

  • 7. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM, Wojtkowska M, Skiba E, Werpachowska I, Tobolczyk J, Kaczmarski M.
    Adv Med Sci; 2009 Feb 17; 54(2):177-82. PubMed ID: 20022856
    [Abstract] [Full Text] [Related]

  • 8. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR, Yap J, Rodriguez-Dimitrescu C, Mazurak V, Ball G, Gilmour S.
    Nutr Clin Pract; 2013 Feb 17; 28(1):101-11. PubMed ID: 23042833
    [Abstract] [Full Text] [Related]

  • 9. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z, Malecka-Tendera E, Matusik P.
    Can J Gastroenterol Hepatol; 2018 Feb 17; 2018():9465784. PubMed ID: 29854716
    [Abstract] [Full Text] [Related]

  • 10. Hepatic steatosis in obese Chinese children.
    Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA.
    Int J Obes Relat Metab Disord; 2004 Oct 17; 28(10):1257-63. PubMed ID: 15278103
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.
    Yetim A, Şahin M, Kandemir İ, Bulakçı B, Aksakal MT, Karapınar E, Sever H, Baş F.
    Lipids Health Dis; 2024 Jul 02; 23(1):208. PubMed ID: 38956572
    [Abstract] [Full Text] [Related]

  • 12. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G, Bjelaković G, Benedeto-Stojanov D, Nagorni A, Brzački V, Marković-Živković B.
    Vojnosanit Pregl; 2016 Oct 02; 73(10):910-20. PubMed ID: 29327896
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
    Chang EJ, Yi DY, Yang HR.
    J Korean Med Sci; 2015 Dec 02; 30(12):1821-7. PubMed ID: 26713058
    [Abstract] [Full Text] [Related]

  • 14. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J.
    Diabetes Res Clin Pract; 2008 Sep 02; 81(3):321-6. PubMed ID: 18571268
    [Abstract] [Full Text] [Related]

  • 15. Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease.
    Bobrus-Chociej A, Flisiak-Jackiewicz M, Daniluk U, Wojtkowska M, Kłusek-Oksiuta M, Tarasów E, Lebensztejn D.
    Acta Biochim Pol; 2018 Oct 31; 65(4):539-544. PubMed ID: 30380561
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L, Di Martino M, Anania C, Andreoli GM, Bezzi M, Catalano C, Chiesa C.
    World J Gastroenterol; 2015 Apr 21; 21(15):4688-95. PubMed ID: 25914480
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM, Farghaly AG, El-Ghitany EM.
    Arab J Gastroenterol; 2014 Jun 21; 15(2):76-81. PubMed ID: 25097051
    [Abstract] [Full Text] [Related]

  • 18. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK, Zhou Y, Sädevirta S, Leivonen M, Arola J, Orešič M, Hyötyläinen T, Yki-Järvinen H.
    J Hepatol; 2016 May 21; 64(5):1167-1175. PubMed ID: 26780287
    [Abstract] [Full Text] [Related]

  • 19. Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    Hua MC, Su HM, Yao TC, Kuo ML, Lai MW, Tsai MH, Huang JL.
    PLoS One; 2017 May 21; 12(7):e0182277. PubMed ID: 28759573
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.